Table 2 Prevalence of hepatitis C (HCV), hepatitis B and HIV in all prisons (n = 9) in the Stockholm County
All | Men | Women | |
|---|---|---|---|
Anti-HCV positivity, na | 80/471 | 71/444 | 9/27 |
(%; 95% CI) | (17.0; 13.6–20.4) | (16.0; 12.6–19.4) | (33.3; 15–6-51.1) |
Viremic infectionb | |||
HCV RNA+/anti-HCV+, n (%; 95% CI) | 53/71 (74.6; 64.5–84.8) | 50/63 (79.4; 69.3–89.4) | 3/8 (37.5; 4.0–71.0) |
HCV RNA+/tested for anti-HCV, n (%; 95% CI) | 53/462 (11.5; 8.6–14.4) | 50/436 (11.5; 8.5–14.4) | 3/26 (11.5; 0.0–23.8) |
Active HBV infection | |||
HBsAg+/tested for HBsAg, n (%; 95% CI) | 9/465 (1.9; 0.7–3.2) | 9/438 (2.1; 0.7–3.4) | 0/27 (0) |
HBsAg+/anti-HBc + , n (%; 95% CI) | 9/65 (13.8; 5.4–22.2) | 9/60 (15.0; 6.0–24.0) | 0/5 (0) |
Anti-HBc positivity | |||
Anti-HBc+/tested for anti-HBc, n (%; 95% CI) | 65/440 (14.8; 11.5–18.1) | 60/414 (14.5; 11.1–17.9) | 5/26 (19.2; 4.1–34.4) |
HIV infection | |||
HIV+/tested for HIV, n (%; 95% CI) | 1/471 (0.2; 0.0–0.6) | 1/444 (0.2; 0.0–0.7) | 0/27 (0) |